A groundbreaking study led by the University of Nevada, Las Vegas (UNLV) has propelled the field of infectious disease surveillance into a new era, focusing on the detection and preemptive control of a deadly, drug-resistant fungus known as Candida auris in healthcare environments. This emerging research harnesses the power of wastewater analysis at a micro-level, offering an almost unprecedented window into the prevalence and evolution of this pathogen within hospitals and long-term care facilities, where it poses significant health threats.
Candida auris, a fungus notorious for causing invasive infections that can devastate vulnerable patients, especially those with compromised immune systems or undergoing invasive medical treatments, has plagued Nevada with one of the United States’ most severe outbreaks. In 2025 alone, Nevada accounted for over one-fifth of the nation’s C. auris cases, a statistic that starkly contrasts with other populous states like California and Texas. Such a disproportionate incidence rate underscores the urgent need for innovative surveillance tools to contain this insidious pathogen.
Previous UNLV research made waves by establishing that sampling untreated wastewater from municipal treatment plants could successfully detect C. auris DNA fragments. This initial discovery was monumental as it proved a non-invasive, community-level surveillance method could track the fungus’s presence outside of traditional clinical testing. However, the latest study, soon to appear in the esteemed journal Nature Communications, pushes the envelope by demonstrating that targeted wastewater sampling directly from hospital sewer lines can reveal the presence of C. auris up to five months before clinical symptoms emerge in patients.
By focusing surveillance efforts closer to the source—specifically within sewer systems servicing hospitals, retirement homes, and long-term care centers—the research team has unveiled a powerful bio-monitoring approach. This facility-level sampling yields markedly higher detection rates and fungal concentrations compared to broader community wastewater sites, illuminating the hidden dynamics of pathogen circulation with finer resolution. This paradigm shift facilitates earlier intervention strategies, potentially stalling outbreaks before they take root and spread within vulnerable populations.
Dr. Edwin Oh, UNLV professor and director of the Center for Water Intelligence and Community Health, eloquently describes this method as a “facility-scale biopsy” that can provide daily updates on microbial threats lurking within healthcare ecosystems. Such timely intelligence equips medical professionals with critical foresight to adjust antifungal treatments proactively, circumventing resistance development and saving lives. The synergy of wastewater surveillance with traditional clinical monitoring promises to redefine infection control protocols in hospital settings globally.
The implications of this research stretch beyond mere detection. Intriguingly, genomic analysis of C. auris strains detected in wastewater samples has revealed adaptive biological mechanisms that confer remarkable resistance to antifungal drugs. These metabolic rewiring patterns and novel stress responses expose potential molecular targets for next-generation therapeutics. Understanding these evolutionary tactics is vital as C. auris has demonstrated resistance to all three primary classes of antifungal medications—a formidable challenge for infection management.
Moreover, the fungus’s resilience extends to its persistence on environmental surfaces within healthcare facilities. C. auris can colonize both dry and moist surfaces, making sterilization efforts tremendously difficult. Its resistance to common surface disinfectants compounds the problem, allowing it to linger on furniture, medical devices, and even clothing. Given this environmental tenacity, surveillance approaches that intercept pathogen signals within wastewater pipelines become even more critical, serving as early warnings that traditional surface sampling cannot provide.
The Southern Nevada Water Authority, alongside UNLV and multiple public health entities, spearheaded this interdisciplinary investigation, integrating environmental science, microbiology, public health, and epidemiology. Their collaborative effort resulted in the compilation of one of the world’s largest genomic repositories of C. auris, a resource instrumental for in-depth study on fungal mutations, transmission patterns, and drug resistance evolution. This depository not only enhances scientific understanding but also fuels the pipeline for novel drug development and vaccine research.
Wastewater surveillance, which gained prominence during the COVID-19 pandemic for tracking viral community spread, now finds a critical new application in fungal pathogen management. This study underscores how environmental samples collected smartly and strategically can reflect real-time microbial epidemiology within closed community systems like hospitals. The methodology exemplifies an innovative public health toolset that transcends standard clinical diagnostics, offering a non-invasive, cost-effective, and rapid surveillance alternative.
The research team’s foresight does not stop at surveillance. They envision integrating genomic insights with molecular biology to design antifungal agents tailored to combat metabolically adapted strains. Additionally, the possibility of developing vaccines to prevent C. auris infections is tantalizingly close, promising a paradigm shift from reactive treatment to proactive prevention. Until then, deploying wastewater intelligence remains a vital interim strategy to safeguard immunocompromised patients and curb devastating outbreaks.
Dr. Daniel Gerrity from the Southern Nevada Water Authority emphasizes that this advanced surveillance technique could revolutionize how healthcare facilities anticipate and manage infectious threats. Unlike reactive clinical testing, which identifies infections post-onset, wastewater-based detection provides a predictive window, guiding preemptive clinical decisions. This capability empowers medical staff to adapt treatment regimens well in advance, decreasing morbidity and mortality associated with resistant fungal outbreaks.
Lanie Chang, a doctoral student at UNLV and co-lead author, encapsulates the transformative potential of this approach: “Wastewater surveillance reshapes timelines, granting healthcare providers and patients an essential head start against drug-resistant strains that previously spread silently until symptomatic recognition.” As the fight against antimicrobial resistance intensifies, such pioneering approaches represent a beacon of hope amid an increasingly perilous infectious disease landscape.
In conclusion, this UNLV-led investigation represents a monumental leap in infectious disease surveillance, melding environmental monitoring with genomic science to confront a daunting public health menace. The capacity to detect deadly, drug-resistant Candida auris months ahead of clinical presentation heralds a new frontier in infection control within hospitals and communal care facilities. As these methods are refined and adopted widely, they promise not only to save lives today but also to redefine prevention strategies for tomorrow’s global healthcare challenges.
Subject of Research: Detection and surveillance of drug-resistant Candida auris in healthcare settings through targeted wastewater sampling and genomic analysis.
Article Title: Wastewater intelligence predicts the emergence of clinically-relevant and drug-resistant Candidozyma auris at healthcare facilities
News Publication Date: April 18, 2026
Web References: Nature Communications Article
Image Credits: Josh Hawkins/UNLV
Keywords: Infectious diseases, Fungal infections, Drug resistance, Medical facilities, Hospitals, Wastewater, Medical treatments, Drug therapy, Disease outbreaks, Drug development, Infectious disease transmission, Genomics, Microbiology
